M2 TAMs cause immunosuppression and promote tumor progression by releasing various matrix metalloproteinases (MMP-7 and MMP-9) and increasing the levels of IL-10, VEGF, IL-12, TGF-β and fibroblast GF. This evidence concerns the gene IL10 and neoplasm.